Nephro Care India (NEPHROCARE-SM) Share Price Falls 13.95% Today

Nephro Care India Share Price fell to Rs 80.50 on 07 September 2026, down Rs 13.05 or 13.95% for the day from the previous close of Rs 93.55. The move took the company’s market capitalisation to Rs 154.23 crore. With the stock trading in the Healthcare space and classified as a Micro Cap, the decline stood out because the intraday range widened sharply and the price was seen at the day’s low at the time of writing.

The supplied market data confirms the fall in price, but it does not identify any company-specific trigger behind the move. That distinction matters. A visible decline can attract attention quickly, yet the dataset only establishes what happened in the market, not why it happened. For anyone tracking Nephro Care India Share Price today, the immediate focus is therefore on price behaviour, valuation and how the company compares with the broader Hospital & Healthcare Services universe.

Nephro Care India (NEPHROCARE-SM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 80.5
Previous Close	Rs 93.55
Today's Move	-Rs 13.05 (-13.95%)
Open	Rs 90.65
High	Rs 92.5
Low	Rs 80.5
Turnover	Rs 0.68 crore
Market Capitalisation	Rs 154.23 crore
Market Cap Category	Micro Cap

Trading data shows a weak session from the open. The stock opened at Rs 90.65, already below the previous close of Rs 93.55, and then moved lower through the day. It touched a high of Rs 92.50 but eventually declined to Rs 80.50, which was both the intraday low and the current price in the supplied snapshot. That pattern suggests selling pressure persisted through the session rather than being to the opening trade.

The distance between the high and low was Rs 12.00, which is a wide intraday range for a company of this size. Turnover came in at Rs 0.68 crore, indicating there was active trading while the stock moved lower. The RSI reading was 45.13, which places the stock in a middle zone rather than at an extreme level in the supplied snapshot. On a purely factual basis, the session can be described as a lower open, an inability to reclaim the previous close, and trading near the day’s low.

Nephro Care India (NEPHROCARE-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 154.23 crore
P/E Ratio	45.78x
P/B Ratio	2.64x
ROE	10.62%
ROCE	14.42%
EPS	Rs 2.04
Book Value Per Share	Rs 35.46
Dividend Yield	0%

On fundamentals, Nephro Care India remains a small listed healthcare company with positive profitability metrics, though the supplied numbers do not show a standout profile relative to the industry. The P/E ratio is 45.78 and the P/B ratio is 2.64. Return metrics show ROE of 10.62% and ROCE of 14.42%. EPS stands at Rs 2.04 and book value per share is Rs 35.46.

These figures provide useful context after a sharp market move. A P/E near 46 times earnings is not exceptionally low, but it also does not screen at a clear premium to the industry median in the supplied data. The P/B ratio of 2.64 suggests the stock is valued above book value, yet below many larger listed peers on the same measure. The dividend yield is shown as 0, so the present dataset does not indicate a cash yield component at the current price.

In simple terms, the numbers point to a company that is profitable and valued on moderate sector-relative multiples, but not one that obviously sits at the top of the peer set on return ratios. That is important when a one-day decline brings Nephro Care India Share Price into the spotlight, because valuation and profitability together usually shape how investors interpret short-term price weakness.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	45.78x
Benchmark Median P/E	46.45x
Benchmark Average P/E	101.64x
Benchmark P/E Range	7.87x to 1,488.32x
Company P/B Ratio	2.64x
Benchmark Median P/B	3.35x
Benchmark Average P/B	4.2x
Company ROE	10.62%
Benchmark Median ROE	12.77%
Benchmark Average ROE	13.51%
Company ROCE	14.42%
Benchmark Median ROCE	15.34%
Benchmark Average ROCE	3.27%
Company Market Capitalisation	Rs 154.23 crore
Benchmark Median Market Cap	Rs 519.09 crore
Benchmark Average Market Cap	Rs 11,295.38 crore

The same-industry benchmark covers 66 companies in Hospital & Healthcare Services, which helps place this stock in context. Nephro Care India’s P/E of 45.78 is slightly below the industry median of 46.45 and well below the average of 101.64. Because the P/E range spans from 7.87 to 1,488.32 across 58 companies with available data, the average is heavily influenced by very high outliers.

Its P/B ratio of 2.64 is below both the median of 3.35 and the average of 4.20 across 66 companies. On profitability, the picture is less favorable relative to the middle of the group. ROE of 10.62% is below the industry median of 12.77% and average of 13.51%, while ROCE of 14.42% is slightly below the median of 15.34%, though above the reported average of 3.27 in the dataset.

Scale is another major factor. At Rs 154.23 crore, the company’s market capitalisation is below the industry median of Rs 519.09 crore and far below the industry average of Rs 11,295.38 crore. This smaller size can matter in day-to-day trading because market participation and price discovery may behave differently from larger, more liquid healthcare names.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,24,661.3	59.66	12.87	23.54	21.73
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	95,989.65	107.57	5.26	12.95	13.93
Max Healthcare Institute	MAXHEALTH	95,871.06	65.8	8.77	14.53	14.97
Fortis Healthcare	FORTIS	68,701.19	65.56	6.76	11.32	14.07
Aster DM Healthcare	ASTERDM	68,496.02	214.94	13.79	9.32	11.46

Peer data underscores how small Nephro Care India is relative to major listed hospital names. Its market capitalisation of Rs 154.23 crore is far below Apollo Hospitals Enterprise at Rs 1,24,661.30 crore, Manipal Health at Rs 95,989.65 crore, Max Healthcare at Rs 95,871.06 crore, Fortis Healthcare at Rs 68,701.19 crore and Aster DM Healthcare at Rs 68,496.02 crore. That scale difference alone can influence both valuation perception and trading behaviour.

On valuation, the company’s P/E of 45.78 is lower than Apollo’s 59.66, Manipal’s 107.57, Max’s 65.80, Fortis’s 65.56 and Aster’s 214.94. Its P/B ratio of 2.64 is also below each of those peers, whose P/B multiples range from 5.26 to 13.79. That places the stock at the lower end of this peer set on both earnings and book-value valuation measures.

Profitability comparison is more mixed. ROE of 10.62% is below Apollo at 23.54%, Manipal at 12.95%, Max at 14.53% and Fortis at 11.32%, but above Aster at 9.32%. ROCE of 14.42% is below Apollo at 21.73% and Max at 14.97%, while slightly above Manipal at 13.93%, Fortis at 14.07% and Aster at 11.46%. In other words, the stock looks cheaper than these large peers on the supplied valuation ratios, but its return profile does not match the strongest names in the group.

Why Investors Are Watching Nephro Care India

• The stock fell 13.95% in a single session to Rs 80.50 from the previous close of Rs 93.55.
• It opened at Rs 90.65, touched a high of Rs 92.50 and traded down to Rs 80.50.
• The current price matched the day’s low in the supplied snapshot, keeping attention on near-term price behaviour.
• P/E of 45.78 is close to the industry median of 46.45, while P/B of 2.64 is below the benchmark median of 3.35.
• ROE of 10.62% and ROCE of 14.42% are positive, but not clearly ahead of sector medians.
• As a Micro Cap stock with market capitalisation of Rs 154.23 crore, it sits well below the scale of large hospital peers.

About Nephro Care India

Nephro Care India is part of the Healthcare sector and operates in the Hospital & Healthcare Services industry. Based on the supplied classification, it belongs to the same listed industry group as hospital and healthcare service providers, although its scale is far smaller than the leading names included in the benchmark and peer tables above.

Track Nephro Care India Share Price on Univest

UseUnivest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

On Univest, investors can track Nephro Care India Share Price with live price updates, market capitalisation, valuation ratios, profitability metrics and broader market context. For readers following the stock after today’s decline, the key is to evaluate short-term price action alongside sector benchmarks and peer positioning rather than relying on unsupported explanations.

Frequently Asked Questions

Why is Nephro Care India Share Price falling today?

Ans. The supplied data confirms that the stock fell 13.95% to Rs 80.50 from the previous close of Rs 93.55. However, the dataset does not identify any company-specific catalyst behind the move.

What is Nephro Care India Share Price today?

Ans. At the time of writing, the stock price stood at Rs 80.50. It was down Rs 13.05 on the day after opening at Rs 90.65 and trading between Rs 92.50 and Rs 80.50.

What is the market cap of Nephro Care India?

Ans. The supplied data shows a market capitalisation of Rs 154.23 crore, placing the company in the Micro Cap category. The company operates in the Healthcare sector. Its P/E ratio is 45.78x.

How does its P/E ratio compare with the industry?

Ans. The company’s P/E ratio is 45.78, which is slightly below the same-industry median of 46.45 and well below the average of 101.64 in the dataset. Its P/B ratio is 2.64x.

How does its P/B ratio compare with the industry?

Ans. Its P/B ratio is 2.64, below the same-industry median of 3.35 and average of 4.20 across 66 companies. The company trades at a P/E ratio of 45.78x. The relevant peer median P/E is 46.45x.

What do ROE and ROCE show?

Ans. ROE stands at 10.62% and ROCE at 14.42%. Both are positive, though each is below the industry median shown in the supplied benchmark data. The relevant peer median ROE is 12.77%.

How does the company compare with larger hospital peers?

Ans. It is much smaller in market capitalisation than peers such as Apollo Hospitals, Manipal Health, Max Healthcare, Fortis and Aster DM Healthcare. Its valuation multiples are lower than all five on the supplied P/E and P/B figures, while profitability comparison.

Which sector and industry does the company belong to?

Ans. Nephro Care India belongs to the Healthcare sector and operates in the Hospital & Healthcare Services industry. The stock belongs to the Healthcare sector. Its industry classification is Hospital & Healthcare Services.